<?xml version="1.0" encoding="UTF-8"?><corpus source="IEPA">  <document PMID="2310821" id="IEPA.d5" origID="264" set="test">    <sentence charOffset="0-190" id="IEPA.d5.s8" origID="427" text="Oxytocin-stimulated inositol phosphate turnover in endometrium of ewes is influenced by stage of the estrous cycle, pregnancy, and intrauterine infusion of ovine conceptus secretory proteins">      <entity charOffset="0-8" id="IEPA.d5.s8.e0" origID="968" text="Oxytocin" />      <entity charOffset="20-38" id="IEPA.d5.s8.e1" origID="969" text="inositol phosphate" />      <interaction e1="IEPA.d5.s8.e0" e2="IEPA.d5.s8.e1" id="IEPA.d5.s8.i0" type="PPI" />    </sentence>    <sentence charOffset="191-557" id="IEPA.d5.s9" origID="428" text="Three experiments (Exp) assessed the influence of stage of the estrous cycle, pregnancy, and intrauterine infusion of ovine conceptus secretory proteins (oCSP) on turnover of inositol trisphosphate (the putative second-messenger for oxytocin-stimulated secretion of prostaglandin F2 alpha) in ovine endometrium during luteolysis and maternal recognition of pregnancy">      <entity charOffset="175-197" id="IEPA.d5.s9.e0" origID="970" text="inositol trisphosphate" />      <entity charOffset="233-241" id="IEPA.d5.s9.e1" origID="971" text="oxytocin" />      <interaction e1="IEPA.d5.s9.e0" e2="IEPA.d5.s9.e1" id="IEPA.d5.s9.i0" type="PPI" />    </sentence>    <sentence charOffset="558-812" id="IEPA.d5.s10" origID="429" text="For each Exp, 100 mg endometrium was incubated, in duplicate, for 2 h with 10 microCi [3H] inositol and treated with 0 or 100 nM oxytocin (OT) for 20 min, then [3H]inositol mono-, bis-, and trisphosphates (IP1, IP2, and IP3, respectively) were quantified">      <entity charOffset="129-137" id="IEPA.d5.s10.e0" origID="972" text="oxytocin" />      <entity charOffset="220-223" id="IEPA.d5.s10.e1" origID="973" text="IP3" />    </sentence>  </document>  <document PMID="3011507" id="IEPA.d6" origID="265" set="test">    <sentence charOffset="0-99" id="IEPA.d6.s11" origID="430" text="Carbachol and oxytocin stimulate the generation of inositol phosphates in the guinea pig myometrium">      <entity charOffset="14-22" id="IEPA.d6.s11.e0" origID="974" text="oxytocin" />      <entity charOffset="51-70" id="IEPA.d6.s11.e1" origID="975" text="inositol phosphates" />      <interaction e1="IEPA.d6.s11.e0" e2="IEPA.d6.s11.e1" id="IEPA.d6.s11.i0" type="PPI" />    </sentence>    <sentence charOffset="100-283" id="IEPA.d6.s12" origID="431" text="In the guinea pig myometrium prelabelled with myo-[2-3H]inositol, carbachol and oxytocin enhanced a concentration-dependent and rapid release of IP3 which preceded that of IP2 and IP1">      <entity charOffset="80-88" id="IEPA.d6.s12.e0" origID="976" text="oxytocin" />      <entity charOffset="145-148" id="IEPA.d6.s12.e1" origID="977" text="IP3" />      <interaction e1="IEPA.d6.s12.e0" e2="IEPA.d6.s12.e1" id="IEPA.d6.s12.i0" type="PPI" />    </sentence>  </document>  <document PMID="7495469" id="IEPA.d7" origID="151" set="test">    <sentence charOffset="0-235" id="IEPA.d7.s13" origID="207" text="Hesperidin, the most important flavanone of Citrus sp., significantly increases HDL and lowers cholesterol, LDL, total lipid and triglyceride plasma levels in normolipidemic rats and in rats with diet- and triton-induced hyperlipidemia">      <entity charOffset="31-40" id="IEPA.d7.s13.e0" origID="450" text="flavanone" />      <entity charOffset="95-106" id="IEPA.d7.s13.e1" origID="451" text="cholesterol" />      <interaction e1="IEPA.d7.s13.e0" e2="IEPA.d7.s13.e1" id="IEPA.d7.s13.i0" type="PPI" />    </sentence>  </document>  <document PMID="8858923" id="IEPA.d29" origID="200" set="test">    <sentence charOffset="0-237" id="IEPA.d29.s61" origID="288" text="This action of beta-amyloid 25-35 is not altered by pretreatment with the calcium channel blockers nifedipine or cobalt, with the depleter of intracellular calcium stores cyclopiazonic acid, or with the phospholipase C inhibitor neomycin">      <entity charOffset="15-27" id="IEPA.d29.s61.e0" origID="630" text="beta-amyloid" />      <entity charOffset="203-218" id="IEPA.d29.s61.e1" origID="631" text="phospholipase C" />    </sentence>  </document>  <document PMID="8882346" id="IEPA.d30" origID="149" set="test">    <sentence charOffset="0-184" id="IEPA.d30.s62" origID="205" text="The influence of myrigalone B, a flavonoid from the fruit exudate of Myrica gale L. on Cu(2+)-induced oxidation of low density lipoprotein from cholesterol fed rabbits was investigated">      <entity charOffset="33-42" id="IEPA.d30.s62.e0" origID="446" text="flavonoid" />      <entity charOffset="144-155" id="IEPA.d30.s62.e1" origID="447" text="cholesterol" />    </sentence>  </document>  <document PMID="9004255" id="IEPA.d35" origID="293" set="test">    <sentence charOffset="0-163" id="IEPA.d35.s86" origID="478" text="Oxytocin (OT) and vasopressin (AVP) stimulate insulin and glucagon release from the pancreas, and evoke insulin secretion from the rat insulinoma cell line, RINm5F">      <entity charOffset="0-8" id="IEPA.d35.s86.e0" origID="1079" text="Oxytocin" />      <entity charOffset="46-53" id="IEPA.d35.s86.e1" origID="1080" text="insulin" />      <entity charOffset="104-111" id="IEPA.d35.s86.e2" origID="1081" text="insulin" />      <interaction e1="IEPA.d35.s86.e0" e2="IEPA.d35.s86.e1" id="IEPA.d35.s86.i0" type="PPI" />      <interaction e1="IEPA.d35.s86.e0" e2="IEPA.d35.s86.e2" id="IEPA.d35.s86.i1" type="PPI" />    </sentence>  </document>  <document PMID="9159224" id="IEPA.d42" origID="71" set="test">    <sentence charOffset="0-145" id="IEPA.d42.s103" origID="85" text="Signal transduction in pancreatic beta-cells: Regulation of insulin secretion by information flow in the phospholipase C/Protein kinase C pathway">      <entity charOffset="60-67" id="IEPA.d42.s103.e0" origID="192" text="insulin" />      <entity charOffset="105-120" id="IEPA.d42.s103.e1" origID="193" text="phospholipase C" />      <interaction e1="IEPA.d42.s103.e0" e2="IEPA.d42.s103.e1" id="IEPA.d42.s103.i0" type="PPI" />    </sentence>    <sentence charOffset="146-341" id="IEPA.d42.s104" origID="86" text="The physiologic regulation of glucose-induced insulin secretion is dependent upon the activation of information flow in the phospholipase C (PLC)/protein kinase C (PKC) signal transduction system">      <entity charOffset="46-53" id="IEPA.d42.s104.e0" origID="194" text="insulin" />      <entity charOffset="124-139" id="IEPA.d42.s104.e1" origID="195" text="phospholipase C" />      <interaction e1="IEPA.d42.s104.e0" e2="IEPA.d42.s104.e1" id="IEPA.d42.s104.i0" type="PPI" />    </sentence>    <sentence charOffset="342-583" id="IEPA.d42.s105" origID="87" text="When rat islet are cultured for short periods, the content and activation of PLC in response to glucose decreases and this biochemical defect in signal transduction is paralleled by significant reductions in glucose-induced insulin secretion">      <entity charOffset="77-80" id="IEPA.d42.s105.e0" origID="196" text="PLC" />      <entity charOffset="224-231" id="IEPA.d42.s105.e1" origID="197" text="insulin" />    </sentence>    <sentence charOffset="584-785" id="IEPA.d42.s106" origID="88" text="Biphasic insulin secretion can be evoked and time-dependent potentiation can be induced in mouse islets by carbachol, an agonist that activates an isozyme of PLC distinct from that activated by glucose">      <entity charOffset="9-16" id="IEPA.d42.s106.e0" origID="198" text="insulin" />      <entity charOffset="158-161" id="IEPA.d42.s106.e1" origID="199" text="PLC" />      <interaction e1="IEPA.d42.s106.e0" e2="IEPA.d42.s106.e1" id="IEPA.d42.s106.i0" type="PPI" />    </sentence>    <sentence charOffset="786-1040" id="IEPA.d42.s107" origID="89" text="When taken in their entirety, the experimental evidence suggests that the activation of PLC is an essential component in the physiologic regulation of insulin secretion and that disordered activation of the enzyme culminates in disordered insulin release">      <entity charOffset="88-91" id="IEPA.d42.s107.e0" origID="200" text="PLC" />      <entity charOffset="151-158" id="IEPA.d42.s107.e1" origID="201" text="insulin" />      <entity charOffset="239-246" id="IEPA.d42.s107.e2" origID="202" text="insulin" />      <interaction e1="IEPA.d42.s107.e0" e2="IEPA.d42.s107.e1" id="IEPA.d42.s107.i0" type="PPI" />    </sentence>  </document>  <document PMID="9202317" id="IEPA.d46" origID="197" set="test">    <sentence charOffset="0-75" id="IEPA.d46.s115" origID="283" text="Amyloid beta protein (25-35) stimulation of phospholipase C in LA-N-2 cells">      <entity charOffset="0-7" id="IEPA.d46.s115.e0" origID="619" text="Amyloid" />      <entity charOffset="44-59" id="IEPA.d46.s115.e1" origID="620" text="phospholipase C" />      <interaction e1="IEPA.d46.s115.e0" e2="IEPA.d46.s115.e1" id="IEPA.d46.s115.i0" type="PPI" />    </sentence>    <sentence charOffset="76-173" id="IEPA.d46.s116" origID="284" text="This phospholipase C stimulation by amyloid beta protein appeared to be pertussis toxin sensitive">      <entity charOffset="5-20" id="IEPA.d46.s116.e0" origID="621" text="phospholipase C" />      <entity charOffset="36-43" id="IEPA.d46.s116.e1" origID="622" text="amyloid" />      <interaction e1="IEPA.d46.s116.e0" e2="IEPA.d46.s116.e1" id="IEPA.d46.s116.i0" type="PPI" />    </sentence>    <sentence charOffset="174-281" id="IEPA.d46.s117" origID="285" text="It is possible that this phospholipase C stimulation by amyloid beta protein is a receptor-mediated process">      <entity charOffset="25-40" id="IEPA.d46.s117.e0" origID="623" text="phospholipase C" />      <entity charOffset="56-63" id="IEPA.d46.s117.e1" origID="624" text="amyloid" />      <interaction e1="IEPA.d46.s117.e0" e2="IEPA.d46.s117.e1" id="IEPA.d46.s117.i0" type="PPI" />    </sentence>    <sentence charOffset="282-494" id="IEPA.d46.s118" origID="286" text="Amyloid beta protein stimulation of phospholipase C was absent from LA-N-2 cells previously treated with norepinephrine, trans-1-amino-1,3-cyclopentanedicarboxylic acid (t-ACPD), bombesin, or amyloid beta peptide">      <entity charOffset="0-7" id="IEPA.d46.s118.e0" origID="625" text="Amyloid" />      <entity charOffset="36-51" id="IEPA.d46.s118.e1" origID="626" text="phospholipase C" />      <entity charOffset="192-199" id="IEPA.d46.s118.e2" origID="627" text="amyloid" />      <interaction e1="IEPA.d46.s118.e0" e2="IEPA.d46.s118.e1" id="IEPA.d46.s118.i0" type="PPI" />    </sentence>    <sentence charOffset="495-689" id="IEPA.d46.s119" origID="287" text="It is suggested that this observed amyloid beta protein stimulation of phospholipase C may be responsible for the elevated quantity of inositol seen in the brains of Alzheimer's disease patients">      <entity charOffset="35-42" id="IEPA.d46.s119.e0" origID="628" text="amyloid" />      <entity charOffset="71-86" id="IEPA.d46.s119.e1" origID="629" text="phospholipase C" />      <interaction e1="IEPA.d46.s119.e0" e2="IEPA.d46.s119.e1" id="IEPA.d46.s119.i0" type="PPI" />    </sentence>  </document>  <document PMID="9243706" id="IEPA.d47" origID="290" set="test">    <sentence charOffset="0-107" id="IEPA.d47.s120" origID="471" text="Effects of oxytocin, arginine-vasopressin and lysine-vasopressin on insulin and glucagon secretion in sheep">      <entity charOffset="11-19" id="IEPA.d47.s120.e0" origID="1062" text="oxytocin" />      <entity charOffset="68-75" id="IEPA.d47.s120.e1" origID="1063" text="insulin" />      <interaction e1="IEPA.d47.s120.e0" e2="IEPA.d47.s120.e1" id="IEPA.d47.s120.i0" type="PPI" />    </sentence>    <sentence charOffset="108-289" id="IEPA.d47.s121" origID="472" text="The effects of the posterior-pituitary peptides oxytocin (OT), arginine-vasopressin (AVP) and lysine-vasopressin (LVP) on insulin and glucagon secretion were examined in adult sheep">      <entity charOffset="48-56" id="IEPA.d47.s121.e0" origID="1064" text="oxytocin" />      <entity charOffset="122-129" id="IEPA.d47.s121.e1" origID="1065" text="insulin" />      <interaction e1="IEPA.d47.s121.e0" e2="IEPA.d47.s121.e1" id="IEPA.d47.s121.i0" type="PPI" />    </sentence>    <sentence charOffset="290-462" id="IEPA.d47.s122" origID="473" text="The maximal insulin responses induced by OT and AVP were very similar, but the threshold and maximal doses of AVP for increasing plasma insulin were higher than those of OT">      <entity charOffset="12-19" id="IEPA.d47.s122.e0" origID="1066" text="insulin" />      <entity charOffset="41-43" id="IEPA.d47.s122.e1" origID="1067" text="OT" />      <entity charOffset="136-143" id="IEPA.d47.s122.e2" origID="1068" text="insulin" />      <entity charOffset="170-172" id="IEPA.d47.s122.e3" origID="1069" text="OT" />      <interaction e1="IEPA.d47.s122.e0" e2="IEPA.d47.s122.e1" id="IEPA.d47.s122.i0" type="PPI" />      <interaction e1="IEPA.d47.s122.e2" e2="IEPA.d47.s122.e3" id="IEPA.d47.s122.i1" type="PPI" />    </sentence>  </document>  <document PMID="9268716" id="IEPA.d49" origID="237" set="test">    <sentence charOffset="0-196" id="IEPA.d49.s126" origID="365" text="Leptin upregulates the expression of uncoupling protein-2 (UCP-2) mRNA in islets of normal rats, but has no effect in islets of obese Zucker Diabetic Fatty (ZDF) rats with mutated leptin receptors">      <entity charOffset="0-6" id="IEPA.d49.s126.e0" origID="836" text="Leptin" />      <entity charOffset="37-57" id="IEPA.d49.s126.e1" origID="837" text="uncoupling protein-2" />      <interaction e1="IEPA.d49.s126.e0" e2="IEPA.d49.s126.e1" id="IEPA.d49.s126.i0" type="PPI" />    </sentence>  </document>  <document PMID="9276734" id="IEPA.d50" origID="65" set="test">    <sentence charOffset="0-343" id="IEPA.d50.s127" origID="68" text="Insulin secretion is regulated by changes in blood glucose, as well as by peptides from the gastrointestinal tract and neurotransmitters that activate the pancreatic islet adenylyl cyclase (e.g., glucagon-like peptide-1) and phospholipase C (PLC) (e.g., acetylcholine) signaling pathways to further potentiate glucose-induced insulin secretion">      <entity charOffset="0-7" id="IEPA.d50.s127.e0" origID="153" text="Insulin" />      <entity charOffset="225-240" id="IEPA.d50.s127.e1" origID="154" text="phospholipase C" />      <entity charOffset="326-333" id="IEPA.d50.s127.e2" origID="155" text="insulin" />      <interaction e1="IEPA.d50.s127.e1" e2="IEPA.d50.s127.e2" id="IEPA.d50.s127.i0" type="PPI" />    </sentence>    <sentence charOffset="344-512" id="IEPA.d50.s128" origID="69" text="However, leptin did constrain the enhanced PLC-mediated insulin secretion characteristic of islets from ob/ob mice, without influencing release from islets of lean mice">      <entity charOffset="43-46" id="IEPA.d50.s128.e0" origID="156" text="PLC" />      <entity charOffset="56-63" id="IEPA.d50.s128.e1" origID="157" text="insulin" />      <interaction e1="IEPA.d50.s128.e0" e2="IEPA.d50.s128.e1" id="IEPA.d50.s128.i0" type="PPI" />    </sentence>    <sentence charOffset="513-711" id="IEPA.d50.s129" origID="70" text="A specific enhancement in PLC-mediated insulin secretion is the earliest reported developmental alteration in insulin secretion from islets of ob/ob mice, and thus a logical target for leptin action">      <entity charOffset="26-29" id="IEPA.d50.s129.e0" origID="158" text="PLC" />      <entity charOffset="39-46" id="IEPA.d50.s129.e1" origID="159" text="insulin" />      <entity charOffset="110-117" id="IEPA.d50.s129.e2" origID="160" text="insulin" />      <interaction e1="IEPA.d50.s129.e0" e2="IEPA.d50.s129.e1" id="IEPA.d50.s129.i0" type="PPI" />    </sentence>    <sentence charOffset="712-836" id="IEPA.d50.s130" origID="71" text="This action of leptin on PLC-mediated insulin secretion was dose-dependent, rapid-onset (i.e., within 3 min), and reversible">      <entity charOffset="25-28" id="IEPA.d50.s130.e0" origID="161" text="PLC" />      <entity charOffset="38-45" id="IEPA.d50.s130.e1" origID="162" text="insulin" />      <interaction e1="IEPA.d50.s130.e0" e2="IEPA.d50.s130.e1" id="IEPA.d50.s130.i0" type="PPI" />    </sentence>    <sentence charOffset="837-1029" id="IEPA.d50.s131" origID="72" text="Leptin was equally effective in constraining the enhanced insulin release from islets of ob/ob mice caused by protein kinase C (PKC) activation, a downstream mediator of the PLC signal pathway">      <entity charOffset="58-65" id="IEPA.d50.s131.e0" origID="163" text="insulin" />      <entity charOffset="174-177" id="IEPA.d50.s131.e1" origID="164" text="PLC" />    </sentence>    <sentence charOffset="1030-1210" id="IEPA.d50.s132" origID="73" text="One function of leptin in control of body composition is thus to target a PKC-regulated component of the PLC-PKC signaling system within islets to prevent hypersecretion of insulin">      <entity charOffset="105-108" id="IEPA.d50.s132.e0" origID="165" text="PLC" />      <entity charOffset="173-180" id="IEPA.d50.s132.e1" origID="166" text="insulin" />    </sentence>  </document>  <document PMID="9291128" id="IEPA.d51" origID="63" set="test">    <sentence charOffset="0-160" id="IEPA.d51.s133" origID="66" text="Insulin stimulates the release of the glycosyl phosphatidylinositol-anchored membrane dipeptidase from 3T3-L1 adipocytes through the action of a phospholipase C">      <entity charOffset="0-7" id="IEPA.d51.s133.e0" origID="149" text="Insulin" />      <entity charOffset="145-160" id="IEPA.d51.s133.e1" origID="150" text="phospholipase C" />      <interaction e1="IEPA.d51.s133.e0" e2="IEPA.d51.s133.e1" id="IEPA.d51.s133.i0" type="PPI" />    </sentence>    <sentence charOffset="161-451" id="IEPA.d51.s134" origID="67" text="The hydrophilic form of MDP released from the cells on stimulation with insulin was recognized by antibodies against the inositol 1,2-cyclic monophosphate cross-reacting determinant, indicating that it had been generated by cleavage of its GPI anchor through the action of a phospholipase C">      <entity charOffset="72-79" id="IEPA.d51.s134.e0" origID="151" text="insulin" />      <entity charOffset="275-290" id="IEPA.d51.s134.e1" origID="152" text="phospholipase C" />      <interaction e1="IEPA.d51.s134.e0" e2="IEPA.d51.s134.e1" id="IEPA.d51.s134.i0" type="PPI" />    </sentence>  </document>  <document PMID="9348240" id="IEPA.d53" origID="289" set="test">    <sentence charOffset="0-280" id="IEPA.d53.s137" origID="470" text="During luteinization of bovine granulosa cells in vitro in the presence of insulin, or insulin plus forskolin, there is a massive upregulation not only of progesterone production, but also of the gene for the peptide hormone oxytocin, with secretion of the peptide into the medium">      <entity charOffset="75-82" id="IEPA.d53.s137.e0" origID="1059" text="insulin" />      <entity charOffset="87-94" id="IEPA.d53.s137.e1" origID="1060" text="insulin" />      <entity charOffset="225-233" id="IEPA.d53.s137.e2" origID="1061" text="oxytocin" />      <interaction e1="IEPA.d53.s137.e0" e2="IEPA.d53.s137.e2" id="IEPA.d53.s137.i0" type="PPI" />      <interaction e1="IEPA.d53.s137.e1" e2="IEPA.d53.s137.e2" id="IEPA.d53.s137.i1" type="PPI" />    </sentence>  </document>  <document PMID="9374680" id="IEPA.d56" origID="61" set="test">    <sentence charOffset="0-98" id="IEPA.d56.s143" origID="59" text="Interleukin-1 beta inhibits phospholipase C and insulin secretion at sites apart from KATP channel">      <entity charOffset="28-43" id="IEPA.d56.s143.e0" origID="133" text="phospholipase C" />      <entity charOffset="48-55" id="IEPA.d56.s143.e1" origID="134" text="insulin" />    </sentence>    <sentence charOffset="99-368" id="IEPA.d56.s144" origID="60" text="Surprisingly, however, when islets were depolarized directly using either of two agonists, glyburide (which does not act via generation of purine nucleotides) or 40 mM K+ (which acts distal to KATP channel), PLC and insulin secretion were again obliterated by IL-1 beta">      <entity charOffset="208-211" id="IEPA.d56.s144.e0" origID="135" text="PLC" />      <entity charOffset="216-223" id="IEPA.d56.s144.e1" origID="136" text="insulin" />    </sentence>    <sentence charOffset="369-664" id="IEPA.d56.s145" origID="61" text="These data (together with the finding that IL-1 beta inhibited Ca(2+)-induced insulin release) suggest that, in addition to its effects on ATP synthesis and thereby on the KATP channel, IL-1 beta has at least two undescribed, distal effects to block both PLC as well as Ca(2+)-induced exocytosis">      <entity charOffset="78-85" id="IEPA.d56.s145.e0" origID="137" text="insulin" />      <entity charOffset="255-258" id="IEPA.d56.s145.e1" origID="138" text="PLC" />    </sentence>  </document>  <document PMID="9449962" id="IEPA.d59" origID="59" set="test">    <sentence charOffset="0-143" id="IEPA.d59.s154" origID="58" text="PKB, which is an important early PI 3-kinase-dependent component of insulin signalling pathways, is also down-regulated by PLC-coupled agonists">      <entity charOffset="68-75" id="IEPA.d59.s154.e0" origID="131" text="insulin" />      <entity charOffset="123-126" id="IEPA.d59.s154.e1" origID="132" text="PLC" />    </sentence>  </document>  <document PMID="9530273" id="IEPA.d64" origID="182" set="test">    <sentence charOffset="0-136" id="IEPA.d64.s161" origID="249" text="Similarly, carbachol, but not AVP or DDAVP, induced a significant increase in membrane-associated protein kinase C (PKC) enzyme activity">      <entity charOffset="30-33" id="IEPA.d64.s161.e0" origID="539" text="AVP" />      <entity charOffset="98-114" id="IEPA.d64.s161.e1" origID="540" text="protein kinase C" />    </sentence>    <sentence charOffset="137-213" id="IEPA.d64.s162" origID="250" text="In contrast, AVP had no effect on the distribution of any PKC isoform tested">      <entity charOffset="13-16" id="IEPA.d64.s162.e0" origID="541" text="AVP" />      <entity charOffset="58-61" id="IEPA.d64.s162.e1" origID="542" text="PKC" />    </sentence>  </document>  <document PMID="9605437" id="IEPA.d68" origID="146" set="test">    <sentence charOffset="0-177" id="IEPA.d68.s169" origID="204" text="The results demonstrate that potent antioxidants, such as flavonoids, protect MM-LDL from lipoperoxidation and preserve their ability to efficiently deliver cholesterol to cells">      <entity charOffset="58-68" id="IEPA.d68.s169.e0" origID="444" text="flavonoids" />      <entity charOffset="157-168" id="IEPA.d68.s169.e1" origID="445" text="cholesterol" />      <interaction e1="IEPA.d68.s169.e0" e2="IEPA.d68.s169.e1" id="IEPA.d68.s169.i0" type="PPI" />    </sentence>  </document>  <document PMID="9621246" id="IEPA.d69" origID="287" set="test">    <sentence charOffset="0-247" id="IEPA.d69.s170" origID="468" text="During wk 6, milk yield and dry matter intake (DMI) were recorded daily, and plasma concentrations of glucose, nonesterified fatty acids, urea, protein, growth hormone, insulin, insulin-like growth factor I, oxytocin, and prolactin were determined">      <entity charOffset="169-176" id="IEPA.d69.s170.e0" origID="1055" text="insulin" />      <entity charOffset="208-216" id="IEPA.d69.s170.e1" origID="1056" text="oxytocin" />    </sentence>  </document>  <document PMID="9654347" id="IEPA.d75" origID="178" set="test">    <sentence charOffset="0-136" id="IEPA.d75.s179" origID="242" text="Concurrent decrease of vasopressin and protein kinase Calpha immunoreactivity during the light phase in the vole suprachiasmatic nucleus">      <entity charOffset="23-34" id="IEPA.d75.s179.e0" origID="524" text="vasopressin" />      <entity charOffset="39-60" id="IEPA.d75.s179.e1" origID="525" text="protein kinase Calpha" />    </sentence>    <sentence charOffset="137-410" id="IEPA.d75.s180" origID="243" text="Mean numbers of AVP- and protein kinase Calpha-immunoreactive neurons were determined in the suprachiasmatic nucleus of common voles, entrained to a 12:12 h light-dark (LD) cycle, at the beginning of the light period (zeitgeber time zero) and 6 h later (zeitgeber time six)">      <entity charOffset="16-19" id="IEPA.d75.s180.e0" origID="526" text="AVP" />      <entity charOffset="25-46" id="IEPA.d75.s180.e1" origID="527" text="protein kinase Calpha" />    </sentence>    <sentence charOffset="411-538" id="IEPA.d75.s181" origID="244" text="At zeitgeber time zero, mean numbers of AVP- and protein kinase Calpha- immunoreactive neurons were 2194 and 9897, respectively">      <entity charOffset="40-43" id="IEPA.d75.s181.e0" origID="528" text="AVP" />      <entity charOffset="49-70" id="IEPA.d75.s181.e1" origID="529" text="protein kinase Calpha" />    </sentence>  </document>  <document PMID="9666341" id="IEPA.d78" origID="177" set="test">    <sentence charOffset="0-123" id="IEPA.d78.s187" origID="240" text="To assess the possible involvement of PKC in AVP and IL-1 action in Leydig cells, the PKC inhibitor Calphostin C was tested">      <entity charOffset="38-41" id="IEPA.d78.s187.e0" origID="518" text="PKC" />      <entity charOffset="45-48" id="IEPA.d78.s187.e1" origID="519" text="AVP" />      <entity charOffset="86-89" id="IEPA.d78.s187.e2" origID="520" text="PKC" />      <interaction e1="IEPA.d78.s187.e0" e2="IEPA.d78.s187.e1" id="IEPA.d78.s187.i0" type="PPI" />    </sentence>    <sentence charOffset="124-243" id="IEPA.d78.s188" origID="241" text="These results confirm that AVP and PMA activate PKC and indicate that IL-1 likely does not activate PKC in Leydig cells">      <entity charOffset="27-30" id="IEPA.d78.s188.e0" origID="521" text="AVP" />      <entity charOffset="48-51" id="IEPA.d78.s188.e1" origID="522" text="PKC" />      <entity charOffset="100-103" id="IEPA.d78.s188.e2" origID="523" text="PKC" />      <interaction e1="IEPA.d78.s188.e0" e2="IEPA.d78.s188.e1" id="IEPA.d78.s188.i0" type="PPI" />    </sentence>  </document>  <document PMID="9878732" id="IEPA.d95" origID="174" set="test">    <sentence charOffset="0-107" id="IEPA.d95.s229" origID="237" text="The distribution of arginine-vasopressin (AVP) cells in the SCN overlapped with that of PKC in both species">      <entity charOffset="20-40" id="IEPA.d95.s229.e0" origID="511" text="arginine-vasopressin" />      <entity charOffset="88-91" id="IEPA.d95.s229.e1" origID="512" text="PKC" />      <interaction e1="IEPA.d95.s229.e0" e2="IEPA.d95.s229.e1" id="IEPA.d95.s229.i0" type="PPI" />    </sentence>    <sentence charOffset="108-365" id="IEPA.d95.s230" origID="238" text="Species differences in the location of the Ca2+-dependent PKC isoforms suggest differences in function such as the relaying of photic or non-photic information to the clock mechanism, or the synchronization of AVP neurons and their subsequent output signals">      <entity charOffset="58-61" id="IEPA.d95.s230.e0" origID="513" text="PKC" />      <entity charOffset="210-213" id="IEPA.d95.s230.e1" origID="514" text="AVP" />    </sentence>  </document>  <document PMID="9924749" id="IEPA.d101" origID="278" set="test">    <sentence charOffset="0-173" id="IEPA.d101.s240" origID="446" text="The two groups were similar in their morning thyroxin, triiodothyronine, TSH, estradiol, cortisol, gastrin, cholecystokinin, somatostatin, oxytocin, insulin and IGF-1 levels">      <entity charOffset="139-147" id="IEPA.d101.s240.e0" origID="1007" text="oxytocin" />      <entity charOffset="149-156" id="IEPA.d101.s240.e1" origID="1008" text="insulin" />    </sentence>  </document>  <document PMID="9990099" id="IEPA.d102" origID="90" set="test">    <sentence charOffset="0-134" id="IEPA.d102.s241" origID="122" text="Constitutive expression of PKABA1 drastically suppressed expression of low- and high-pI alpha-amylase and protease genes induced by GA">      <entity charOffset="88-101" id="IEPA.d102.s241.e0" origID="275" text="alpha-amylase" />      <entity charOffset="132-134" id="IEPA.d102.s241.e1" origID="276" text="GA" />      <interaction e1="IEPA.d102.s241.e0" e2="IEPA.d102.s241.e1" id="IEPA.d102.s241.i0" type="PPI" />    </sentence>  </document>  <document PMID="10026817" id="IEPA.d103" origID="277" set="test">    <sentence charOffset="0-172" id="IEPA.d103.s242" origID="445" text="The bovine ovarian granulosa cell model is a primary culture system where under stimulation by insulin or IGF-I and LH the endogenous oxytocin gene is massively upregulated">      <entity charOffset="95-102" id="IEPA.d103.s242.e0" origID="1005" text="insulin" />      <entity charOffset="134-142" id="IEPA.d103.s242.e1" origID="1006" text="oxytocin" />      <interaction e1="IEPA.d103.s242.e0" e2="IEPA.d103.s242.e1" id="IEPA.d103.s242.i0" type="PPI" />    </sentence>  </document>  <document PMID="10069063" id="IEPA.d105" origID="88" set="test">    <sentence charOffset="0-96" id="IEPA.d105.s244" origID="120" text="The deduced consensus closely resembled gibberellin response elements in alpha-amylase promoters">      <entity charOffset="40-51" id="IEPA.d105.s244.e0" origID="271" text="gibberellin" />      <entity charOffset="73-86" id="IEPA.d105.s244.e1" origID="272" text="alpha-amylase" />      <interaction e1="IEPA.d105.s244.e0" e2="IEPA.d105.s244.e1" id="IEPA.d105.s244.i0" type="PPI" />    </sentence>  </document>  <document PMID="10087452" id="IEPA.d108" origID="276" set="test">    <sentence charOffset="0-91" id="IEPA.d108.s251" origID="440" text="Long-term changes in gastrin, cholecystokinin and insulin in response to oxytocin treatment">      <entity charOffset="50-57" id="IEPA.d108.s251.e0" origID="992" text="insulin" />      <entity charOffset="73-81" id="IEPA.d108.s251.e1" origID="993" text="oxytocin" />      <interaction e1="IEPA.d108.s251.e0" e2="IEPA.d108.s251.e1" id="IEPA.d108.s251.i0" type="PPI" />    </sentence>    <sentence charOffset="92-340" id="IEPA.d108.s252" origID="441" text="The present study was designed to investigate how repeated injections of oxytocin influence plasma levels of vagally controlled hormones such as gastrin, cholecystokinin (CCK), insulin and somatostatin, as well as of endogenous oxytocin and glucose">      <entity charOffset="73-81" id="IEPA.d108.s252.e0" origID="994" text="oxytocin" />      <entity charOffset="177-184" id="IEPA.d108.s252.e1" origID="995" text="insulin" />      <entity charOffset="228-236" id="IEPA.d108.s252.e2" origID="996" text="oxytocin" />      <interaction e1="IEPA.d108.s252.e0" e2="IEPA.d108.s252.e1" id="IEPA.d108.s252.i0" type="PPI" />    </sentence>    <sentence charOffset="341-527" id="IEPA.d108.s253" origID="442" text="In addition, both insulin and CCK levels were decreased in response to the oxytocin treatment when measured 3 and 10 days after the last injection (ANOVA; insulin p &lt; 0.01, CCK p &lt; 0.05)">      <entity charOffset="18-25" id="IEPA.d108.s253.e0" origID="997" text="insulin" />      <entity charOffset="75-83" id="IEPA.d108.s253.e1" origID="998" text="oxytocin" />      <entity charOffset="155-162" id="IEPA.d108.s253.e2" origID="999" text="insulin" />      <interaction e1="IEPA.d108.s253.e0" e2="IEPA.d108.s253.e1" id="IEPA.d108.s253.i0" type="PPI" />    </sentence>    <sentence charOffset="528-867" id="IEPA.d108.s254" origID="443" text="When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with oxytocin or saline, plasma levels of insulin and CCK increased significantly (p &lt; 0.05) in the oxytocin-treated rats, when compared to saline-treated controls receiving clonidine only">      <entity charOffset="156-164" id="IEPA.d108.s254.e0" origID="1000" text="oxytocin" />      <entity charOffset="193-200" id="IEPA.d108.s254.e1" origID="1001" text="insulin" />      <entity charOffset="251-259" id="IEPA.d108.s254.e2" origID="1002" text="oxytocin" />    </sentence>    <sentence charOffset="868-1039" id="IEPA.d108.s255" origID="444" text="In conclusion, these results show that oxytocin induces long-lasting changes in plasma levels of gastrin, CCK and insulin, without affecting somatostatin or glucose levels">      <entity charOffset="39-47" id="IEPA.d108.s255.e0" origID="1003" text="oxytocin" />      <entity charOffset="114-121" id="IEPA.d108.s255.e1" origID="1004" text="insulin" />      <interaction e1="IEPA.d108.s255.e0" e2="IEPA.d108.s255.e1" id="IEPA.d108.s255.i0" type="PPI" />    </sentence>  </document>  <document PMID="10098498" id="IEPA.d110" origID="170" set="test">    <sentence charOffset="0-202" id="IEPA.d110.s264" origID="227" text="Signal transduction of arginine vasopressin-induced arachidonic acid release in H9c2 cardiac myoblasts: role of Ca2+ and the protein kinase C-dependent activation of p42 mitogen-activated protein kinase">      <entity charOffset="23-43" id="IEPA.d110.s264.e0" origID="491" text="arginine vasopressin" />      <entity charOffset="125-141" id="IEPA.d110.s264.e1" origID="492" text="protein kinase C" />      <interaction e1="IEPA.d110.s264.e0" e2="IEPA.d110.s264.e1" id="IEPA.d110.s264.i0" type="PPI" />    </sentence>    <sentence charOffset="203-367" id="IEPA.d110.s265" origID="228" text="The Ca2+ ionophore, A23187 or ionomycin, mimicked the effect of AVP, whereas the protein kinase C (PKC) activator, TPA, only induced a slight increase in AA release">      <entity charOffset="64-67" id="IEPA.d110.s265.e0" origID="493" text="AVP" />      <entity charOffset="81-97" id="IEPA.d110.s265.e1" origID="494" text="protein kinase C" />    </sentence>    <sentence charOffset="368-747" id="IEPA.d110.s266" origID="229" text="Western blots demonstrated expression of PKCalpha, betaI, epsilon, delta, and zeta in H9c2 cells; PKC inhibitors (staurosporine or Ro 31-8220) or down-regulation of PKCalpha, betaI, epsilon, and delta by long-term (24 h) TPA treatment caused a partial blockade of the AVP-induced response, whereas the A23187-induced AA release was unaffected by down-regulation of these isoforms">      <entity charOffset="98-101" id="IEPA.d110.s266.e0" origID="495" text="PKC" />      <entity charOffset="165-173" id="IEPA.d110.s266.e1" origID="496" text="PKCalpha" />      <entity charOffset="268-271" id="IEPA.d110.s266.e2" origID="497" text="AVP" />    </sentence>    <sentence charOffset="748-1003" id="IEPA.d110.s267" origID="230" text="AVP- or TPA-induced activation and tyrosine phosphorylation of p42 MAPK were completely blocked by down-regulation of PKCalpha, betaI, epsilon, and delta, but still occurred, together with the cytosolic PLA2 mobility shift, in the absence of external Ca2+">      <entity charOffset="0-3" id="IEPA.d110.s267.e0" origID="498" text="AVP" />      <entity charOffset="118-126" id="IEPA.d110.s267.e1" origID="499" text="PKCalpha" />      <interaction e1="IEPA.d110.s267.e0" e2="IEPA.d110.s267.e1" id="IEPA.d110.s267.i0" type="PPI" />    </sentence>    <sentence charOffset="1004-1232" id="IEPA.d110.s268" origID="231" text="These results show that AVP-induced AA release in H9c2 cells is secondary to activation of the V1 receptor/Gq protein/PLCP pathway, leading to an influx of extracellular Ca2+ and activation of PKCalpha, betaI, epsilon, and delta">      <entity charOffset="24-27" id="IEPA.d110.s268.e0" origID="500" text="AVP" />      <entity charOffset="193-201" id="IEPA.d110.s268.e1" origID="501" text="PKCalpha" />      <interaction e1="IEPA.d110.s268.e0" e2="IEPA.d110.s268.e1" id="IEPA.d110.s268.i0" type="PPI" />    </sentence>  </document>  <document PMID="10331408" id="IEPA.d115" origID="44" set="test">    <sentence charOffset="0-173" id="IEPA.d115.s277" origID="40" text="Overexpression of G11alpha and isoforms of phospholipase C in islet  beta-cells reveals a lack of correlation between inositol phosphate  accumulation and insulin secretion.">      <entity charOffset="43-58" id="IEPA.d115.s277.e0" origID="95" text="phospholipase C" />      <entity charOffset="155-162" id="IEPA.d115.s277.e1" origID="96" text="insulin" />    </sentence>    <sentence charOffset="174-341" id="IEPA.d115.s278" origID="41" text="It has been suggested that insulin secretion from pancreatic islets may be  mediated in part by activation of phospholipases C (PLCs) and  phosphoinositide hydrolysis.">      <entity charOffset="27-34" id="IEPA.d115.s278.e0" origID="97" text="insulin" />      <entity charOffset="110-126" id="IEPA.d115.s278.e1" origID="98" text="phospholipases C" />      <interaction e1="IEPA.d115.s278.e0" e2="IEPA.d115.s278.e1" id="IEPA.d115.s278.i0" type="PPI" />    </sentence>    <sentence charOffset="342-562" id="IEPA.d115.s279" origID="42" text="The purpose of this study was to determine  whether the relatively modest fuel-stimulated insulin secretion responses  of rodent beta-cell lines might be explained by inadequate expression or  activation of PLC isoforms.">      <entity charOffset="90-97" id="IEPA.d115.s279.e0" origID="99" text="insulin" />      <entity charOffset="207-210" id="IEPA.d115.s279.e1" origID="100" text="PLC" />      <interaction e1="IEPA.d115.s279.e0" e2="IEPA.d115.s279.e1" id="IEPA.d115.s279.i0" type="PPI" />    </sentence>    <sentence charOffset="563-923" id="IEPA.d115.s280" origID="43" text="Adenovirus-mediated overexpression of PLC-delta1, -beta1, or  -beta3 in INS-1 or betaG 40/110 cells results in little or no enhancement  in inositol phosphate (IP) accumulation and no improvement in insulin  secretion when the cells are stimulated with glucose or carbachol, despite  the fact that the overexpressed proteins are fully active in cell  extracts.">      <entity charOffset="38-41" id="IEPA.d115.s280.e0" origID="101" text="PLC" />      <entity charOffset="199-206" id="IEPA.d115.s280.e1" origID="102" text="insulin" />    </sentence>    <sentence charOffset="924-1077" id="IEPA.d115.s281" origID="44" text="Overexpression of PLC-beta1 or -beta3 in normal rat islets  elicits a larger increase in IP accumulation but, again, has no effect on  insulin secretion.">      <entity charOffset="18-21" id="IEPA.d115.s281.e0" origID="103" text="PLC" />      <entity charOffset="135-142" id="IEPA.d115.s281.e1" origID="104" text="insulin" />    </sentence>    <sentence charOffset="1078-1366" id="IEPA.d115.s282" origID="45" text="Because the effect of carbachol on insulin secretion is  thought to be mediated through muscarinic receptors that link to the Gq/11  class of heterotrimeric G proteins, we also overexpressed G11alpha in  INS-1 cells, either alone or in concert with overexpression of PLC-beta1  or -beta3.">      <entity charOffset="35-42" id="IEPA.d115.s282.e0" origID="105" text="insulin" />      <entity charOffset="267-270" id="IEPA.d115.s282.e1" origID="106" text="PLC" />    </sentence>    <sentence charOffset="1367-1583" id="IEPA.d115.s283" origID="46" text="Overexpression of G11alpha enhances IP accumulation, an effect  slightly potentiated by co-overexpression of PLC-beta1 or -beta3, but  these maneuvers do not affect glucose or carbachol-stimulated insulin  secretion.">      <entity charOffset="109-112" id="IEPA.d115.s283.e0" origID="107" text="PLC" />      <entity charOffset="197-204" id="IEPA.d115.s283.e1" origID="108" text="insulin" />    </sentence>  </document>  <document PMID="10364387" id="IEPA.d116" origID="85" set="test">    <sentence charOffset="0-208" id="IEPA.d116.s284" origID="113" text="In the present study we found that at increasing GA concentrations, increasing numbers of barley (Hordeum vulgare) cells showed the enhanced amylase secretion and vacuolation characteristic of the GA response">      <entity charOffset="49-51" id="IEPA.d116.s284.e0" origID="256" text="GA" />      <entity charOffset="141-148" id="IEPA.d116.s284.e1" origID="257" text="amylase" />      <entity charOffset="197-199" id="IEPA.d116.s284.e2" origID="258" text="GA" />      <interaction e1="IEPA.d116.s284.e0" e2="IEPA.d116.s284.e1" id="IEPA.d116.s284.i0" type="PPI" />    </sentence>  </document>  <document PMID="10441778" id="IEPA.d123" origID="143" set="test">    <sentence charOffset="0-167" id="IEPA.d123.s296" origID="202" text="The activity of catalase was found to be significantly enhanced in the tissues of normal and cholesterol fed rats administered 1 mg flavonoid from brinjal/100 g BW/day">      <entity charOffset="93-104" id="IEPA.d123.s296.e0" origID="440" text="cholesterol" />      <entity charOffset="132-141" id="IEPA.d123.s296.e1" origID="441" text="flavonoid" />    </sentence>  </document>  <document PMID="10476058" id="IEPA.d124" origID="81" set="test">    <sentence charOffset="0-197" id="IEPA.d124.s297" origID="110" text="By comparison with the promoters of alpha-amylase genes, which are also induced by GA, we suggest that GARE is coupled with the upstream element and the pyrimidine box to form a GA response complex">      <entity charOffset="36-49" id="IEPA.d124.s297.e0" origID="247" text="alpha-amylase" />      <entity charOffset="83-85" id="IEPA.d124.s297.e1" origID="248" text="GA" />      <entity charOffset="178-180" id="IEPA.d124.s297.e2" origID="249" text="GA" />      <interaction e1="IEPA.d124.s297.e0" e2="IEPA.d124.s297.e1" id="IEPA.d124.s297.i0" type="PPI" />    </sentence>  </document>  <document PMID="10477111" id="IEPA.d125" origID="193" set="test">    <sentence charOffset="0-275" id="IEPA.d125.s298" origID="277" text="Our data demonstrate, that activation of mitogen activated protein (MAP) kinase alone is sufficient to promote APP secretion, whereas inhibition of MAP kinase will reduce APP secretion only when phospholipase Cgamma or phosphatidylinositol 3-kinase are additionally inhibited">      <entity charOffset="111-114" id="IEPA.d125.s298.e0" origID="606" text="APP" />      <entity charOffset="171-174" id="IEPA.d125.s298.e1" origID="607" text="APP" />      <entity charOffset="195-215" id="IEPA.d125.s298.e2" origID="608" text="phospholipase Cgamma" />    </sentence>  </document>  <document PMID="10615945" id="IEPA.d135" origID="26" set="test">    <sentence charOffset="0-241" id="IEPA.d135.s323" origID="38" text="These results suggest that, in isolated white adipocytes, the released adenosine acts as a helper and/or a positive regulator for insulin in the release of leptin via an activation of adenosine A1 receptors that involves the PLC-PKC pathway.">      <entity charOffset="130-137" id="IEPA.d135.s323.e0" origID="91" text="insulin" />      <entity charOffset="225-228" id="IEPA.d135.s323.e1" origID="92" text="PLC" />      <interaction e1="IEPA.d135.s323.e0" e2="IEPA.d135.s323.e1" id="IEPA.d135.s323.i0" type="PPI" />    </sentence>  </document>  <document PMID="10665337" id="IEPA.d136" origID="271" set="test">    <sentence charOffset="0-221" id="IEPA.d136.s324" origID="436" text="The etiology for diabetes mellitus in PWS may be related to the morbid obesity and consequent insulin resistance, because a decrease of oxytocin neurons and leptin resistance in PWS may cause hyperphagia, inducing obesity">      <entity charOffset="94-101" id="IEPA.d136.s324.e0" origID="984" text="insulin" />      <entity charOffset="136-144" id="IEPA.d136.s324.e1" origID="985" text="oxytocin" />    </sentence>  </document>  <document PMID="10757636" id="IEPA.d142" origID="217" set="test">    <sentence charOffset="0-241" id="IEPA.d142.s341" origID="316" text="METHODS: We have therefore studied possible associations of the Gln27Glu and the Gly16Arg polymorphisms in the beta2AR with BMI, plasma leptin and UCP-1 mRNA expression in the intraperitoneal adipose tissue in a population of Caucasian women">      <entity charOffset="136-142" id="IEPA.d142.s341.e0" origID="699" text="leptin" />      <entity charOffset="147-152" id="IEPA.d142.s341.e1" origID="700" text="UCP-1" />    </sentence>    <sentence charOffset="242-404" id="IEPA.d142.s342" origID="317" text="Furthermore, no association was found between the Gln27Glu or the Gly16Arg polymorphisms and plasma leptin or adipose tissue UCP-1 gene expression in either group">      <entity charOffset="100-106" id="IEPA.d142.s342.e0" origID="701" text="leptin" />      <entity charOffset="125-130" id="IEPA.d142.s342.e1" origID="702" text="UCP-1" />    </sentence>  </document>  <document PMID="10786701" id="IEPA.d145" origID="189" set="test">    <sentence charOffset="0-187" id="IEPA.d145.s346" origID="262" text="Aggregated beta amyloid peptide 1-40 decreases Ca2+- and cholinergic receptor-mediated phosphoinositide degradation by alteration of membrane and cytosolic phospholipase C in brain cortex">      <entity charOffset="16-23" id="IEPA.d145.s346.e0" origID="571" text="amyloid" />      <entity charOffset="156-171" id="IEPA.d145.s346.e1" origID="572" text="phospholipase C" />      <interaction e1="IEPA.d145.s346.e0" e2="IEPA.d145.s346.e1" id="IEPA.d145.s346.i0" type="PPI" />    </sentence>    <sentence charOffset="188-416" id="IEPA.d145.s347" origID="263" text="The effects of full-length amyloid beta protein, A(beta) (1-40), on phosphoinositide-specific phospholipase C (PLC) were investigated in synaptic plasma membranes (SPM) and cytosol prepared from the cerebral cortex of adult rats">      <entity charOffset="27-34" id="IEPA.d145.s347.e0" origID="573" text="amyloid" />      <entity charOffset="94-109" id="IEPA.d145.s347.e1" origID="574" text="phospholipase C" />    </sentence>    <sentence charOffset="417-512" id="IEPA.d145.s348" origID="264" text="Aggregated A(beta) also decreased significantly the level of diacylglycerol, the product of PLC">      <entity charOffset="11-18" id="IEPA.d145.s348.e0" origID="575" text="A(beta)" />      <entity charOffset="92-95" id="IEPA.d145.s348.e1" origID="576" text="PLC" />    </sentence>    <sentence charOffset="513-608" id="IEPA.d145.s349" origID="265" text="This additionally supports the inhibitory effect of A(beta) on membrane-bound and cytosolic PLC">      <entity charOffset="52-59" id="IEPA.d145.s349.e0" origID="577" text="A(beta)" />      <entity charOffset="92-95" id="IEPA.d145.s349.e1" origID="578" text="PLC" />      <interaction e1="IEPA.d145.s349.e0" e2="IEPA.d145.s349.e1" id="IEPA.d145.s349.i0" type="PPI" />    </sentence>    <sentence charOffset="609-763" id="IEPA.d145.s350" origID="266" text="Moreover, A(beta) (1-40) significantly decreased the basal activity of the PIP2-PLC in SPM and the enzyme activity regulated through cholinergic receptors">      <entity charOffset="10-24" id="IEPA.d145.s350.e0" origID="579" text="A(beta) (1-40)" />      <entity charOffset="75-83" id="IEPA.d145.s350.e1" origID="580" text="PIP2-PLC" />      <interaction e1="IEPA.d145.s350.e0" e2="IEPA.d145.s350.e1" id="IEPA.d145.s350.i0" type="PPI" />    </sentence>  </document>  <document PMID="10908568" id="IEPA.d167" origID="20" set="test">    <sentence charOffset="0-355" id="IEPA.d167.s403" origID="25" text="Pretreatment of HEK-293 cells for 2 min with carbachol, a mAChR agonist, lysophosphatidic acid, or ATP, followed by agonist washout, strongly increased (by 2-3-fold) maximal PLC stimulation (measured &gt;/=40 min later) by epidermal growth factor and platelet-derived growth factor, but not insulin, and largely enhanced PLC sensitivity to these RTK agonists">      <entity charOffset="174-177" id="IEPA.d167.s403.e0" origID="59" text="PLC" />      <entity charOffset="288-295" id="IEPA.d167.s403.e1" origID="60" text="insulin" />      <entity charOffset="318-321" id="IEPA.d167.s403.e2" origID="61" text="PLC" />    </sentence>  </document>  <document PMID="10923281" id="IEPA.d170" origID="118" set="test">    <sentence charOffset="0-110" id="IEPA.d170.s410" origID="166" text="Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels">      <entity charOffset="52-58" id="IEPA.d170.s410.e0" origID="363" text="leptin" />      <entity charOffset="89-103" id="IEPA.d170.s410.e1" origID="364" text="neuropeptide Y" />    </sentence>    <sentence charOffset="111-386" id="IEPA.d170.s411" origID="167" text="Obesity occurs in 60% of women after menopause and is characterized by an excess of adipose tissue that depends on several orexigenic (neuropeptide Y (NPY) stimulates carbohydrate ingestion, galanin stimulates fat intake) and anorectic (leptin, cholecystokinin (CCK)) factors">      <entity charOffset="135-149" id="IEPA.d170.s411.e0" origID="365" text="neuropeptide Y" />      <entity charOffset="237-243" id="IEPA.d170.s411.e1" origID="366" text="leptin" />    </sentence>    <sentence charOffset="387-463" id="IEPA.d170.s412" origID="168" text="Both leptin and insulin can reduce hypothalamic NPY production and secretion">      <entity charOffset="5-11" id="IEPA.d170.s412.e0" origID="367" text="leptin" />      <entity charOffset="48-51" id="IEPA.d170.s412.e1" origID="368" text="NPY" />      <interaction e1="IEPA.d170.s412.e0" e2="IEPA.d170.s412.e1" id="IEPA.d170.s412.i0" type="PPI" />    </sentence>    <sentence charOffset="464-780" id="IEPA.d170.s413" origID="169" text="We investigated basal levels of serum leptin, CCK, galanin and NPY in 16 non-obese premenopausal women, in 15 obese premenopausal women (body mass index (BMI) 34.6 +/- 1.3 SD) and in ten obese postmenopausal women (BMI 34.7 +/- 1.5 SD) to determine the relationship between obesity, menopause and these neuropeptides">      <entity charOffset="38-44" id="IEPA.d170.s413.e0" origID="369" text="leptin" />      <entity charOffset="63-66" id="IEPA.d170.s413.e1" origID="370" text="NPY" />    </sentence>    <sentence charOffset="781-1029" id="IEPA.d170.s414" origID="170" text="Significantly increased leptin and galanin levels in postmenopausal obese women coupled with decreased NPY levels revealed some changes in the neuropeptides regulating eating behavior, which may be the reason for the onset of postmenopausal obesity">      <entity charOffset="24-30" id="IEPA.d170.s414.e0" origID="371" text="leptin" />      <entity charOffset="103-106" id="IEPA.d170.s414.e1" origID="372" text="NPY" />    </sentence>  </document>  <document PMID="11024559" id="IEPA.d189" origID="102" set="test">    <sentence charOffset="0-168" id="IEPA.d189.s453" origID="146" text="These findings are consistent with increased leptin signaling to the NPY and POMC neurons in the ARC by physiological levels of circulating leptin during normal feeding">      <entity charOffset="45-51" id="IEPA.d189.s453.e0" origID="324" text="leptin" />      <entity charOffset="69-72" id="IEPA.d189.s453.e1" origID="325" text="NPY" />      <entity charOffset="140-146" id="IEPA.d189.s453.e2" origID="326" text="leptin" />    </sentence>  </document>  <document PMID="11053526" id="IEPA.d195" origID="98" set="test">    <sentence charOffset="0-143" id="IEPA.d195.s469" origID="132" text="Leptin Rapidly Inhibits Hypothalamic Neuropeptide Y Secretion and Stimulates Corticotropin-Releasing Hormone Secretion in Adrenalectomized Mice">      <entity charOffset="0-6" id="IEPA.d195.s469.e0" origID="295" text="Leptin" />      <entity charOffset="37-51" id="IEPA.d195.s469.e1" origID="296" text="Neuropeptide Y" />      <interaction e1="IEPA.d195.s469.e0" e2="IEPA.d195.s469.e1" id="IEPA.d195.s469.i0" type="PPI" />    </sentence>    <sentence charOffset="144-371" id="IEPA.d195.s470" origID="133" text="Leptin may rapidly inhibit food intake by altering the secretion of hypothalamic neuropeptides such as neuropeptide Y (NPY), a stimulator of food intake, and/or corticotropin-releasing hormone (CRH), an inhibitor of food intake">      <entity charOffset="0-6" id="IEPA.d195.s470.e0" origID="297" text="Leptin" />      <entity charOffset="103-117" id="IEPA.d195.s470.e1" origID="298" text="neuropeptide Y" />      <interaction e1="IEPA.d195.s470.e0" e2="IEPA.d195.s470.e1" id="IEPA.d195.s470.i0" type="PPI" />    </sentence>    <sentence charOffset="372-655" id="IEPA.d195.s471" origID="134" text="We measured concentrations of NPY and CRH in specific hypothalamic regions [i.e., arcuate nucleus (ARC), paraventricular nucleus (PVN), ventromedial nucleus and dorsomedial nucleus] of 7- to 8-wk-old lean and ob/ob mice at 1 or 3 h after intracerebroventricular leptin administration">      <entity charOffset="30-33" id="IEPA.d195.s471.e0" origID="299" text="NPY" />      <entity charOffset="262-268" id="IEPA.d195.s471.e1" origID="300" text="leptin" />    </sentence>    <sentence charOffset="656-759" id="IEPA.d195.s472" origID="135" text="No rapid-onset effects of leptin on hypothalamic NPY or CRH concentrations were observed in intact mice">      <entity charOffset="26-32" id="IEPA.d195.s472.e0" origID="301" text="leptin" />      <entity charOffset="49-52" id="IEPA.d195.s472.e1" origID="302" text="NPY" />    </sentence>    <sentence charOffset="760-868" id="IEPA.d195.s473" origID="136" text="The addition of leptin to hypothalamic preparations from intact mice also did not alter NPY or CRH secretion">      <entity charOffset="16-22" id="IEPA.d195.s473.e0" origID="303" text="leptin" />      <entity charOffset="88-91" id="IEPA.d195.s473.e1" origID="304" text="NPY" />    </sentence>    <sentence charOffset="869-1046" id="IEPA.d195.s474" origID="137" text="Within 20 min after exposure to leptin, NPY secretion from hypothalamic preparations obtained from adrenalectomized mice was lowered by 27% and CRH secretion was elevated by 51%">      <entity charOffset="32-38" id="IEPA.d195.s474.e0" origID="305" text="leptin" />      <entity charOffset="40-43" id="IEPA.d195.s474.e1" origID="306" text="NPY" />      <interaction e1="IEPA.d195.s474.e0" e2="IEPA.d195.s474.e1" id="IEPA.d195.s474.i0" type="PPI" />    </sentence>    <sentence charOffset="1047-1267" id="IEPA.d195.s475" origID="138" text="The current study demonstrates that leptin rapidly influences the secretion of hypothalamic NPY and CRH and that these actions of leptin within the hypothalamus are restrained by the presence of endogenous corticosterone">      <entity charOffset="36-42" id="IEPA.d195.s475.e0" origID="307" text="leptin" />      <entity charOffset="92-95" id="IEPA.d195.s475.e1" origID="308" text="NPY" />      <entity charOffset="130-136" id="IEPA.d195.s475.e2" origID="309" text="leptin" />      <interaction e1="IEPA.d195.s475.e0" e2="IEPA.d195.s475.e1" id="IEPA.d195.s475.i0" type="PPI" />    </sentence>  </document></corpus>